By integrating data from innovative molecular profiling technologies, new opportunities for Precision Medicine arise. The Tumor Profiler Study is a multi-centre, multi-method observational trial. It combines a prospective diagnostic approach that probes the relevance of in-depth tumor profiling for clinical decision-making, with an exploratory approach to improve our biological understanding of the disease. In this highly collaborative project, the Bodenmiller lab contributes its expertise in single-cell CyTOF and imaging mass cytometry (IMC).
See Irmisch et al., Cancer Cell.
Read more about the Tumor Profiler Project in UZH news.